Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Non-malignant Disease
What is the role of RT in neurosarcoidosis that is refractory to a variety of medical therapies?
What dose/fractionation should be used?
Would you consider giving memantine in these situations?
Related Questions
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
How do you approach counseling patients on the use of low-dose radiation therapy for osteoarthritis who are concurrently receiving parathyroid hormone anabolic treatment?
Does the presence of thrombus in the sinus affect your decision between fractionated radiation and SRS for recurrent grade 1 meningioma?
Would patients receiving targeted therapies be eligible for TTFields for brain metastases?
What is your approach for LINAC based radiosurgery when dealing with benign perioptic lesions very close to the optics apparatus?
How long would you stop standard GBM radiotherapy if the patient had a fall with minor head trauma?
How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?